Archive | Innovation Challenge RSS feed for this section

Don’t Wait! There is Still Time to Apply to RESI Innovation Challenge. Deadline May 1st…Go for It!

25 Apr

By Gregory Mannix, Vice President International Business Development, LSN

The deadline to enter the RESI Innovation Challenge for the RESI Philadelphia event (June 3rd) is fast approaching, coming up May 1st. I would encourage every fundraising CEO and scientist/entrepreneur who will be in Philadelphia in early June to go for it! The RESI Innovation Challenge is a great way to instantly get your company from regional mode to global mode as RESI Philly is going to be loaded with international biotech, medtech and digital health partners and investors. A great strategy is to apply for the Innovation Challenge and if you are one of the 35 early stage startups selected, you can use that prestigious selection to help garner more partnering meetings. We are expecting over 300 investors in attendance at RESI, and the ratio of investors to startups is typically 1 to 1. These global investors and partners come to RESI seeking innovative technologies with high potential to scale in global markets. The RESI partnering system is designed to ensure that meetings between investors and startups are based on a strong fit for each other’s criteria, and we have often heard that makes RESI a much more productive place to meet than other events.

We encourage all applicants to read our article on How To Be Successful in the RESI Innovation Challenge. There is not much time left to apply – interested applicants, please complete your online application through our application portal here or submit your PDF application and supplementary materials by sending them to We look forward to receiving your submissions!  Here is a list of the companies that placed in the top three at the last 4 RESI events.  Take a look at the companies who have won in the past – they represent a very compelling and diversified group of technologies.

Company Description of Technology Location
Miniaturized auto injector for patients who need to carry emergency injectable medications North Carolina
Light emitting swallow-able capsule for treating Chrome’s disease Israel
Electronic Catheter Guidance System England
Online speech tele-therapy solutions Israel
Medical devices for ICU monitoring Taiwan
Revolutionizes blood flow imaging through PET scanning Denmark
Doctors office  MRI imaging California
NICU feeding management and lactation analytics Pennsylvania
Minimally invasive device for treating post surgical pain Pennsylvania
Micro-machine for monitoring and treating ventricular heart conditions Massachusetts
Novel brain imaging for monitoring sedation Massachusetts
Noninvasive devices for monitoring and treating hypertension and migraine headaches California

RESI Europe 2019 Innovation Challenge – Check Out the Winners

28 Mar

By Claire Jeong, Director of Research, Asia BD, LSN


On Monday, March 25th, companies from North America, Western Europe, Israel, etc. showcased their technologies in the Vienna Marriott Hotel exhibition hall, where LSN organized the first ever (and quite successful!) RESI Europe conference. As usual, conference attendees were provided with 5 pieces of “RESI Cash” which they could use to “invest” in the companies of their choice. Again, congratulations to all finalists who were selected to present, and we hope RESI was able to serve as a great venue for creating valuable connections. But most importantly, we are excited to announce the Top 3 winners of this Innovation Challenge – please check their details below!

First Place: Rx Bandz

Rx Bandz provides a game-changing, cost-effective solution for millions of people globally who need to carry emergency injectable medication. Nearly 60% of them do not carry their prescribed auto-injectors with them. MiniJect,™ our miniaturized auto-injector, delivers a wide range of injectable drugs. Its small size and intuitive design make it easy to carry and simple to use. The first drug delivery platform for epinephrine will allow active patients to take it with them, thus increasing compliance and saving lives. Our world-class team has designed and tested a medical device that is also an attractive accessory. We have been deemed eligible for FDA- 505(B)2, the expedited pathway to market.  We have the options of either licensing the device for multiple medications, or taking it to market. Accessory attachments to the MiniJect,™ offer yet another revenue stream.

Jessica Walsh, Founder & CEO, Rx Bandz


Second Place: PhotoPill Medical

PhotoPill Medical develops a revolutionary state-of-the-art disposable swallow-able capsule for treating Crohn’s disease flare-ups and as a preventive treatment in-between flares, by implementing Photo-Bio-Modulation treatment (PBMt) and gut microbiota modulation light-protocols as it travels through the intestine. The PhotoPill capsule is personalized for each patient based on disease location and individual peristaltic rate. Photopill’s unique disruptive technology would be a first of its kind for intestinal tissue treatment and gut bacteria related disorders. This would be a safe, easy to use, cost effective solution for a huge market and a painful problem. PhotoPill has demonstrated excellent pre-clinical results, and preliminary data in IBD Proctitis patients, using Photopill’s dedicated rectal device. PhotoPill has strong IP portfolio and strong and experienced team.

Sharon Ben Yehuda, Co-Founder, PhotoPill Medical


Third Place: Pathfinder Medical

Pathfinder Medical is developing a novel electronic catheter guidance system that will enable clinicians to connect blood vessels in a minimally invasive way. This platform technology has a variety of clinical applications in peripheral vascular and dialysis procedures, together representing a €4.5 billion yearly market. Open surgery is the current standard for preparing patients for dialysis and bypassing blocked peripheral arteries. High failure rates (approximately 50%) in both cases present a serious danger to life and require repeat procedures, for US dialysis patients alone this adds up to $4.6 billion per year. The ePATH catheter platform aims to eliminate need for open surgery in several vascular procedures, improving outcomes and reducing the burden on patients and healthcare systems.

Sorin Popa, Founder & CEO, Pathfinder Medical

If you missed out on the opportunity to compete in the RESI Europe Innovation Challenge, we would be happy to take your applications for our upcoming RESI Philadelphia on Monday, June 3rd. Please visit our online application portal at to get your application started!

Now Offering RESI Philadelphia Early Bird Rates

Call for Global Innovation

28 Mar

By Gregory Mannix, Vice President International Business Development, LSN

Once again, Life Science Nation is making a call for global life science companies to compete in the Innovation Challenge at RESI Philadelphia. We encourage companies from around the globe to complete the application to compete in this year’s edition. As is always the case, there is no cost to apply or to participate in the Challenge, and finalists will have the opportunity to present a poster at RESI designating their country of origin in the corresponding section of the Exhibition Hall. Finalists will gain excellent visibility in front of hundreds of global investors and strategics who will be attending RESI, so be sure to apply using the following link:

%d bloggers like this: